US rheumatologists in favour of distinct names for biosimilars

Posted 22/04/2016

Following the approval of the infliximab biosimilar Inflectra (infliximab-dyyb) the American College of Rheumatology (ACR) has issued a statement supporting...

Payers in US getting ready for biosimilars Reports | Posted 22/04/2016
Generics perceptions in patients, pharmacists a... Generics/Research | Posted 22/04/2016
Biosimilars: the clinical perspective Biosimilars/Research | Posted 22/04/2016
New administration route for epoetin alfa biosi... Biosimilars/News | Posted 22/04/2016
Australia announces price cuts for common presc... Policies & Legislation | Posted 22/04/2016
Sun Pharma to buy 14 drug brands from Novartis... Generics/News | Posted 22/04/2016
A multidisciplinary perspective on biosimilars Biosimilars/Research | Posted 15/04/2016
Substitution of generic antiepileptic drugs Generics/Research | Posted 15/04/2016
Biosimilars: management of clinical issues Biosimilars/Research | Posted 15/04/2016
BioOutsource launches ready-to-use biosimilarit... Biosimilars/News | Posted 15/04/2016
Apotex launches generic of nasal allergy treatment Generics/News | Posted 15/04/2016
India caps prices of 530 essential drugs Policies & Legislation | Posted 15/04/2016
FDA approves infliximab biosimilar Inflectra Biosimilars/News | Posted 08/04/2016
EMA recommends approval of infliximab biosimila... Biosimilars/News | Posted 08/04/2016
Biosimilars of insulin glargine Biosimilars/General | Posted 08/04/2016
European regulatory pathways for biosimilars Biosimilars/Research | Posted 08/04/2016
Teva launches generic acamprosate in US Generics/News | Posted 08/04/2016
IPRF template for summary information for biosi... Biosimilars/General | Posted 01/04/2016
How the biosimilars market is changing Biosimilars/Research | Posted 01/04/2016
Biologicals: characteristics that make them uni... Biosimilars/Research | Posted 01/04/2016
Impact of South Korea’s new drug–pricing policy... Generics/Research | Posted 01/04/2016
Biocon receives Japanese approval for insulin g... Biosimilars/News | Posted 01/04/2016
Idaho governor signs biosimilars substitution bill Policies & Legislation | Posted 01/04/2016
Costs and prices of entecavir to treat Hepatitis B Generics/Research | Posted 25/03/2016
IGBA opposes WHO biological qualifier Biosimilars/General | Posted 25/03/2016
Impact of breast cancer generics in Europe Reports | Posted 25/03/2016
Biosimilars: a new challenge in the current pha... Biosimilars/Research | Posted 25/03/2016
Oncobiologics and Premier make biosimilars deal Pharma News | Posted 25/03/2016
FDA approves Teva’s Viagra generic Generics/News | Posted 25/03/2016
Epoetin alfa biosimilar effective in treating a... Biosimilars/Research | Posted 25/03/2016
Lupin and Gavis to divest generics to appease U... Generics/General | Posted 25/03/2016
Pharmacovigilance for mAbs Biosimilars/Research | Posted 18/03/2016
US doctors poised to prescribe biosimilars Biosimilars/General | Posted 18/03/2016
Oregon passes biosimilars substitution law Policies & Legislation | Posted 18/03/2016
Benefits and concerns related to biosimilars Biosimilars/Research | Posted 18/03/2016
Is India ready to use only generics? Generics/Research | Posted 18/03/2016
Merck Group starts phase III trial for adalimum... Biosimilars/News | Posted 18/03/2016
FDA lifts import ban on Chinese API to prevent... Generics/General | Posted 18/03/2016
Extrapolation of indications for mAbs Biosimilars/Research | Posted 11/03/2016
Kentucky Senate passes biosimilars substitution... Policies & Legislation | Posted 11/03/2016
Hilary Clinton goes after Valeant for ‘predator... Generics/General | Posted 11/03/2016


Switching between originator and follow-on iron-sucrose Posted 22/04/2016

Researchers from France describe and compare the haematological parameters an...


Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015

Generics News Research General


Biosimilars News Research General